Related Experiment Video
Updated: May 28, 2025

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
What Does Long-Term Control in Atopic Dermatitis Look Like?
Shanthi Narla1, Zelma C Chiesa Fuxench2, Katrina Abuabara3
1From the Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Defining and measuring long-term control in atopic dermatitis (AD) is challenging due to its varied nature. Achieving disease modification through effective long-term control strategies is crucial for managing AD and its comorbidities.
Area of Science:
- Dermatology
- Immunology
Background:
- Atopic dermatitis (AD) is a complex skin condition with heterogeneous presentation.
- Measuring long-term control and defining flares in AD lacks consensus due to individual patient experiences.
Purpose of the Study:
- To critically examine the definition, measurement, and importance of long-term control in atopic dermatitis.
- To explore clinical rationale, assessment approaches, mechanistic underpinnings, and evidence for long-term control with systemic AD treatments.
Main Methods:
- Critical review of existing literature on atopic dermatitis long-term control.
- Examination of current systemic treatments and their long-term efficacy.
- Exploration of potential disease modification and remission strategies.
Main Results:
- Limited consensus exists on defining AD flares and long-term control.
- Disease modification, impacting the disease and its comorbidities, is key to long-term control.
- Current research on long-term efficacy of systemic AD therapies is ongoing, requiring larger studies.
Conclusions:
- Achieving deep or therapy-free remission in AD may be possible by addressing multiple facets of long-term control.
- Further research with extended follow-up is necessary to validate reduced dosing strategies for patients in remission.
- Future AD therapies may focus on modulating innate and adaptive immunity for disease modification.
More Related Videos
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...